Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Completed 25 Recruiting 13 Terminated 7 Active not recruiting 5 Unknown 4 Not yet recruiting 3 Withdrawn 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 6 Stomach Neoplasms 5 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Prostatic Neoplasms 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Breast Neoplasms 4 Pancreatic Neoplasms 3 Neoplasms 3 Myelodysplastic Syndromes 3 Glioma 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Nasopharyngeal Carcinoma 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Diffuse Intrinsic Pontine Glioma 2 Warts 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thrombocythemia, Essential 1

Interventions

lutetium Lu 177 dotatate 1 Sunitinib 1 Hydroxyurea 1 Everolimus 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × Meningioma × Clear all

NCT06955169 2026-05-22

MOMENTUM-1

RTOG Foundation, Inc.

Phase 2 Suspended

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡